-
Abemaciclib, sold
under the
brand name
Verzenio among others, is a
medication for the
treatment of
advanced or
metastatic breast cancers. It was developed...
- HR-positive, HER2-negative
advanced breast cancer in
combination with
abemaciclib or
palbociclib in
women with
disease progression after endocrine therapy...
-
notable pharmaceutical agents which contain a
benzimidazole group include abemaciclib, bendamustine, dabigatran, daridorexant, and glasdegib. In
printed circuit...
-
blockade of CDK4 and CDK6).
Other experimental CDK4/6
inhibitors include abemaciclib and ribociclib.
Cancer stem
cells (or cancer-initiating cells) are thought...
-
undergoing clinical trials. A
phase II
clinical study investigating abemaciclib is
underway in
patients with
pretreated or
untreated DDL. Preliminary...
- used in
combination with CDK4/6
inhibitors (palbociclib, ribociclib, or
abemaciclib). When one
endocrine therapy fails, most will
benefit from transitioning...
- L01EE05
Mirdametinib L01EF01
Palbociclib L01EF02
Ribociclib L01EF03
Abemaciclib L01EG01
Temsirolimus L01EG02
Everolimus L01EG03
Ridaforolimus L01EG04...
-
Enzyme inhibitors FI (Tipifarnib§) CDK
inhibitors (
Abemaciclib Alvocidib†
Palbociclib Ribociclib Seliciclib†) PrI
Bortezomib Carfilzomib Oprozomib Ixazomib...
-
Enzyme inhibitors FI (Tipifarnib§) CDK
inhibitors (
Abemaciclib Alvocidib†
Palbociclib Ribociclib Seliciclib†) PrI
Bortezomib Carfilzomib Oprozomib Ixazomib...
-
Enzyme inhibitors FI (Tipifarnib§) CDK
inhibitors (
Abemaciclib Alvocidib†
Palbociclib Ribociclib Seliciclib†) PrI
Bortezomib Carfilzomib Oprozomib Ixazomib...
